Table 2. Demographic and laboratory findings of dengue-positive patients.

	Dengue Clinical Parameters	Mild (n = 45)	Moderate (n = 46)	Severe (n = 21)	p-values
Age	Age	27 (18–33)	26 (19–31.75)	35 (18–43)	0.14	b
Gender	Gender F|M	15|30	17|29	4|17	0.34	a
NS1 Ag	NS1 antigen	3.22 (0.83–3.60)	3.5 (0.86–3.5)	3.5 (1.9–3.5)	0.75	b
CBC	Total Leucocyte Count (TLC)	5 (4.6–5.9)	3 (2.5–3.575)	2.7 (2.3–3.1)	< .001	b
	RBC Count	4.76 (4.51–4.99)	4.835 (4.58–5.02)	4.78 (4.51–5.58)	0.76	b
	Packed Cell, Volume	41.2 (40.1–42.8)	42.25 (38.4–44.22)	43.9 (40.4–46.3)	0.18	b
	Platelet Count	175 (155–202)	160 (150–165)	125 (112–135)	< .001	b
	Neutrophils	75.9 (66.7–79.5)	63.3 (58.1–68.65)	62.6 (57.3–73)	< .001	b
	Lymphocytes	14.1 (9.4–21.3)	24.5 (20.3–31.975)	26 (15.8–32.7)	< .001	b
	Monocytes	9.8 (8–12)	10 (7.85–11.475)	9 (6.9–11)	0.32	b
	Eosinophils	0.2 (0–0.725)	0.2 (0.1–0.875)	0.5 (0.1–1)	0.32	b
	Basophils	0.5 (0.3–0.6)	0.6 (0.225–0.8)	0.5 (0.3–0.8)	0.69	b
	Hb	13.6 (12.75–14.3)	13.9 (12.52–14.5)	14.1 (13.1–15.3)	0.28	b
LFT	Total Protein	7.3 (7–7.6)	6.7 (6.5–7.3)	6.7 (6.05–7.125)	0.03	b
	Albumin	4.4 (4.05–4.5)	4 (3.8–4.15)	4 (3.675–4.1)	0.05	b
	Globulin	3.1 (2.95–3.3)	3 (2.65–3.15)	2.65 (2.3–2.925)	0.06	b
	A.G. ratio	1.4 (1.3–1.55)	1.3 (1.2–1.5)	1.55 (1.375–1.6)	0.19	b
	Bilirubin (Total)	0.7 (0.55–0.8)	0.4 (0.3–0.55)	0.75 (0.5–0.9)	0.02	b
	Bilirubin (Direct)	0.135 (0.12–0.17)	0.09 (0.07–0.13)	0.17 (0.13–0.23)	0.02	b
	Bilirubin (Indirect)	0.56 (0.43–0.615)	0.31 (0.24–0.42)	0.55 (0.39–0.71)	0.03	b
	SGOT- Aspartate Transaminase (AST)	41 (34.5–76)	59 (44–80.5)	97.5 (74.25–141.5)	0.03	b
	SGPT- Alanine Transaminase (ALT)	42 (20–95)	41 (25.5–59)	66 (51.75–80.25)	0.13	b
	AST/ALT Ratio	0.93 (0.82–1.725)	1.48 (1.13–1.95)	1.705 (1.2–2.17)	0.08	b
	Alkaline Phosphatase	67 (60–89)	80 (59.5–100)	82.5 (59.75–124.25)	0.61	b
	GGTP (Gamma GT), Serum	37 (24.5–46.5)	19 (14–41)	49 (32–82)	0.08	b

a-chi square; b-kruskal wallis